拜瑞妥最佳服药时间

(Rivaroxaban) is a coagulation factor Xa inhibitor that inhibits the generation of thrombin and the formation of thrombus. Xarelto is used to treat deep vein thrombosis and pulmonary embolism. Xarelto may also be used to prevent stroke in patients with atrial fibrillation who do not have heart valve disease. Xarelto may also reduce the risk of deep vein thrombosis, such as pulmonary embolism, in patients after hip or knee replacement surgery. Today we will learn more about the best time to take Xarelto.

The recommended dose of Xarelto (rivaroxaban) is 10 mg of Xarelto taken orally once daily. If the wound has stopped bleeding, the first medication should be administered between 6-10 hours after surgery. The length of treatment is determined by each patient's risk of VTE, i.e. by the type of orthopedic surgery the patient has undergone.

For patients undergoing major hip surgery, a 5-week course of Xarelto (rivaroxaban) is recommended. For patients undergoing major knee surgery, a recommended course of treatment is 2 weeks. If a dose is missed, the patient should take Xarelto immediately and continue taking the medication once a day the next day. Patients can take Xarelto with a meal or alone.

Treat DVT (venous thrombosis) and reduce the risk of acute DVT recurrence and PE

The recommended dose of Xarelto for initial treatment of acute DVT is 15 mg twice daily for the first three weeks, followed by 20 mg once daily for maintenance treatment and to reduce the risk of DVT recurrence and PE.

For use in adult patients with non-valvular atrial fibrillation to reduce the risk of stroke and systemic embolism

The recommended dose of Xarelto is 20 mg once a day, which is also the maximum recommended dose. For patients with low body weight and advanced age (>75 years old), doctors can use 15 mg once a day as appropriate based on the patient's condition.

Things to note are:

Close observation is recommended throughout anticoagulation therapy. Premature discontinuation of Xarelto (rivaroxaban) increases the risk of thromboembolism

Premature discontinuation of any oral anticoagulant, including Xarelto (rivaroxaban), in the absence of adequate alternative anticoagulation therapy will increase the risk of thromboembolic events. In clinical trials, an increased incidence of stroke was observed during switching from Xarelto to warfarin in patients with non-valvular atrial fibrillation. If Xarelto must be discontinued prematurely for reasons other than pathological bleeding or completion of therapy, consider administering an alternative anticoagulant.

The above is the content of how to take Rivaroxaban. I hope it can help you!

Recommended related hot articles: /newsDetail/76541.html